<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR520.html">Part 520
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 520.1265  Lincomycin and spectinomycin powder.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. The following salts of lincomycin and  spectinomycin are present in a soluble powder in the ratio of 1 to 2 on  the basis of equivalency of lincomycin base to equivalency of  spectinomycin base:</p><p class="depth2"><em>(1)</em> Lincomycin hydrochloride monohydrate and spectinomycin sulfate  tetrahydrate.</p><p class="depth2"><em>(2)</em> Lincomycin hydrochloride monohydrate and spectinomycin  dihydrochloride pentahydrate.</p><p class="depth1"><em>(b)</em> Sponsors. See sponsors in Sec. 510.600(c) of this chapter for  use as in paragraph (d) of this section.</p><p class="depth2"><em>(1)</em> of  this section.</p><p class="depth2"><em>(2)</em> of this section.</p><p class="depth1"><em>(c)</em> Tolerances. See Sec. Sec. 556.360 and 556.600 of this chapter.</p><p class="depth1"><em>(d)</em> Conditions of use in chickens--</p><p class="depth2"><em>(1)</em> Amount. 2 grams of antibiotic  activity per gallon of drinking water; administer as the sole source of  water for the first 5 to 7 days of life.</p><p class="depth2"><em>(2)</em> Indications for use. As an aid in the control of airsacculitis  caused by either Mycoplasma synoviae or M. gallisepticum susceptible to  lincomycin-spectinomycin and complicated chronic respiratory disease  (air sac infection) caused by Escherichia coli and M. gallisepticum  susceptible to lincomycin-spectinomycin.  [69 FR 13220, Mar. 22, 2004, as amended at 70 FR 40881, July 15, 2005;  71 FR 71038, Dec. 8, 2006; 77 FR 56770, Sept. 14, 2012; 78 FR 28823, May  20, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
